의학 연구 트렌드

AI가 선별한 이번 주 29개 전문과의 주요 논문

마지막 업데이트: 2026년 5월 11일

심장내과5

영향력 2

Day-of-the-week variation in ischemic stroke admissions in patients with atrial fibrillation.

발표일: 2026-12-01

Annals of medicine

MediLens 수록일: 2026-05-12

This study investigates the variation in ischemic stroke admissions among patients with atrial fibrillation (AF) based on the day of the week. Analyzing data from the nationwide FinACAF study, which included 13,781 patients with a mean age of 79.2 years, the results show significant differences i...

PubMed에서 읽기
영향력 3

Wrist-Measured Nighttime Home BP and Left Ventricular Hypertrophy: The WISDOM-HMOD Study.

발표일: 2026-05-11

Hypertension (Dallas, Tex. : 1979)

MediLens 수록일: 2026-05-12

The WISDOM-HMOD study evaluated the relationship between nighttime blood pressure measured by a wrist-type monitor and left ventricular hypertrophy in 1218 patients with hypertension or heart failure. Results showed an average nighttime systolic/diastolic BP of 110.5±13.0/63.5±8.8 mm Hg, with 70....

PubMed에서 읽기
영향력 3

Gene Therapy for Cardiomyopathy: Tools, Targets, and Trials.

발표일: 2026-05-11

Circulation. Heart failure

MediLens 수록일: 2026-05-12

This review addresses the significant advancements in cardiac gene therapy for cardiomyopathy, highlighting the transition of adeno-associated virus-mediated gene replacement into early-phase clinical trials. It notes improvements in biomarkers like NT-proBNP and discusses the challenges in deliv...

PubMed에서 읽기
영향력 3

Improved Cardiac Function and Glycemic Control in Elderly Diabetic Patients Through Structured Case Management After CABG.

발표일: 2026-05-11

Medical science monitor : international medical journal of experimental and clinical research

MediLens 수록일: 2026-05-12

This study evaluated the impact of a structured, multidisciplinary case management model on cardiac function and glycemic control in elderly patients with coronary heart disease and diabetes undergoing off-pump CABG. A total of 168 patients were randomized to receive either routine care or an enh...

PubMed에서 읽기
영향력 3

Finerenone and Empagliflozin in Type 2 Diabetes.

발표일: 2026-05-11

Cardiology in review

MediLens 수록일: 2026-05-12

This study highlights the critical role of sodium-glucose cotransporter 2 inhibitors and nonsteroidal mineralocorticoid receptor antagonists in reducing cardiovascular and kidney disease risks in patients with type 2 diabetes. Empagliflozin showed significant benefits in reducing cardiovascular m...

PubMed에서 읽기

매일 맞춤형 요약을 받아보세요

전 세계 의사들이 AI 문헌 리뷰로 아침을 시작합니다. 매일 오전 7시 이메일로 발송.

7일 무료 체험 시작